PT900214E
(pt)
*
|
1996-05-04 |
2002-03-28 |
Yuhan Corp |
Processo para a preparacao de derivados da pirimidina
|
US6252076B1
(en)
|
1996-05-04 |
2001-06-26 |
Yuhan Corporation |
Process for preparation of pyrimidine derivatives
|
BR9712392A
(pt)
*
|
1996-10-29 |
2000-01-25 |
Yuhan Corp |
Processos para preparar 5,6-dimetil-2-(4-fluorofenil-amino) -4- (1-metil-1,2,3,4 - tetraidroisoquinolin - 2 -il) pirimidina, 4 - halogeno - 2 - (4 - fluorofenilamino) -5,6 -dimetil-pirimidina e 1-metil-1,2,3,4-tetraidroisoquinolina, e, derivado de pirimidina
|
WO1998042699A1
(fr)
*
|
1997-03-26 |
1998-10-01 |
Taisho Pharmaceutical Co., Ltd. |
Derives de 4-tetrahydropyridylpyrimidine
|
IN188411B
(de)
*
|
1997-03-27 |
2002-09-21 |
Yuhan Corp |
|
AU8181098A
(en)
*
|
1997-07-03 |
1999-01-25 |
Du Pont Pharmaceuticals Company |
Aryl-and arylamino-substituted heterocycles as corticotropin releasing hormone antagonists
|
ES2270612T3
(es)
|
1998-08-29 |
2007-04-01 |
Astrazeneca Ab |
Compuestos de pirimidina.
|
WO2000012485A1
(en)
|
1998-08-29 |
2000-03-09 |
Astrazeneca Ab |
Pyrimidine compounds
|
KR100272471B1
(ko)
*
|
1998-11-17 |
2000-11-15 |
김선진 |
신규의 피리미딘 유도체 및 그의 제조방법
|
GB9828511D0
(en)
|
1998-12-24 |
1999-02-17 |
Zeneca Ltd |
Chemical compounds
|
WO2000042025A1
(fr)
*
|
1999-01-14 |
2000-07-20 |
Meiji Seika Kaisha, Ltd. |
Inhibiteurs de poly(adp-ribose) polymerase consistant en des derives de pyrimidine
|
US6852739B1
(en)
*
|
1999-02-26 |
2005-02-08 |
Nitromed Inc. |
Methods using proton pump inhibitors and nitric oxide donors
|
GB9905075D0
(en)
|
1999-03-06 |
1999-04-28 |
Zeneca Ltd |
Chemical compounds
|
GB9907658D0
(en)
|
1999-04-06 |
1999-05-26 |
Zeneca Ltd |
Chemical compounds
|
GB9919778D0
(en)
|
1999-08-21 |
1999-10-27 |
Zeneca Ltd |
Chemical compounds
|
US7365047B1
(en)
|
1999-09-28 |
2008-04-29 |
The Regents Of The University Of California |
Use of pentagastrin to inhibit gastric acid secretion or as a diuretic
|
ATE396978T1
(de)
|
1999-10-07 |
2008-06-15 |
Amgen Inc |
Triazin-kinase-hemmer
|
AU3704101A
(en)
*
|
2000-02-17 |
2001-08-27 |
Amgen Inc |
Kinase inhibitors
|
GB0004886D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
GB0004887D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
GB0004888D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
GB0004890D0
(en)
|
2000-03-01 |
2000-04-19 |
Astrazeneca Uk Ltd |
Chemical compounds
|
GB0007371D0
(en)
|
2000-03-28 |
2000-05-17 |
Astrazeneca Uk Ltd |
Chemical compounds
|
GB0016877D0
(en)
|
2000-07-11 |
2000-08-30 |
Astrazeneca Ab |
Chemical compounds
|
US7105530B2
(en)
|
2000-12-21 |
2006-09-12 |
Smithkline Beecham Corporation |
Pyrimidineamines as angiogenesis modulators
|
GB0103926D0
(en)
|
2001-02-17 |
2001-04-04 |
Astrazeneca Ab |
Chemical compounds
|
GB0113041D0
(en)
|
2001-05-30 |
2001-07-18 |
Astrazeneca Ab |
Chemical compounds
|
US8206741B2
(en)
|
2001-06-01 |
2012-06-26 |
Pozen Inc. |
Pharmaceutical compositions for the coordinated delivery of NSAIDs
|
TW200302728A
(en)
|
2002-02-01 |
2003-08-16 |
Novartis Ag |
Substituted amines as IgE inhibitors
|
JP2005524672A
(ja)
|
2002-03-09 |
2005-08-18 |
アストラゼネカ アクチボラグ |
Cdk阻害活性を有するイミダゾリル置換ピリミジン誘導体
|
GB0205693D0
(en)
|
2002-03-09 |
2002-04-24 |
Astrazeneca Ab |
Chemical compounds
|
GB0205688D0
(en)
|
2002-03-09 |
2002-04-24 |
Astrazeneca Ab |
Chemical compounds
|
GB0205690D0
(en)
|
2002-03-09 |
2002-04-24 |
Astrazeneca Ab |
Chemical compounds
|
EP1534278A4
(de)
*
|
2002-08-01 |
2006-09-06 |
Nitromed Inc |
Nitrosierte protonenpumpen-hemmer, zusammensetzungen und anwendungsverfahren
|
GB0311276D0
(en)
|
2003-05-16 |
2003-06-18 |
Astrazeneca Ab |
Chemical compounds
|
GB0311274D0
(en)
|
2003-05-16 |
2003-06-18 |
Astrazeneca Ab |
Chemical compounds
|
JP2006528640A
(ja)
*
|
2003-07-22 |
2006-12-21 |
ニューロジェン・コーポレーション |
置換ピリジン−2−イルアミン類縁体
|
EP1911754B1
(de)
|
2003-08-13 |
2013-10-09 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl-Peptidase-Hemmer
|
BRPI0414238A
(pt)
*
|
2003-09-09 |
2006-10-31 |
Ono Pharmaceutical Co |
antagonistas de crf e compostos heterobicìclicos
|
CN1874772A
(zh)
|
2003-11-03 |
2006-12-06 |
阿斯利康(瑞典)有限公司 |
治疗隐匿性胃食管反流的咪唑并[1,2-a]吡啶衍生物
|
TW200528101A
(en)
|
2004-02-03 |
2005-09-01 |
Astrazeneca Ab |
Chemical compounds
|
ATE518858T1
(de)
|
2004-09-03 |
2011-08-15 |
Yuhan Corp |
Pyrroloä3,2-cüpyridinderivate und herstellungsverfahren dafür
|
CA2579127C
(en)
|
2004-09-03 |
2011-08-02 |
Yuhan Corporation |
Pyrrolo[3,2-b]pyridine derivatives and processes for the preparation thereof
|
KR100958829B1
(ko)
|
2004-09-03 |
2010-05-25 |
주식회사유한양행 |
피롤로[2,3-c]피리딘 유도체 및 그의 제조방법
|
US20060165797A1
(en)
*
|
2005-01-12 |
2006-07-27 |
Pozen Inc. |
Dosage form for treating gastrointestinal disorders
|
US7803817B2
(en)
*
|
2005-05-11 |
2010-09-28 |
Vecta, Ltd. |
Composition and methods for inhibiting gastric acid secretion
|
US7981908B2
(en)
|
2005-05-11 |
2011-07-19 |
Vecta, Ltd. |
Compositions and methods for inhibiting gastric acid secretion
|
CA2623374A1
(en)
|
2005-09-30 |
2007-04-05 |
Astrazeneca Ab |
Imidazo [1,2-a] pyridine having anti-cell-proliferation activity
|
US7776873B2
(en)
*
|
2005-12-01 |
2010-08-17 |
Yuhan Corporation |
Method for treating damage to gastric mucosa
|
WO2007078874A2
(en)
*
|
2005-12-30 |
2007-07-12 |
Cogentus Pharmaceuticals, Inc. |
Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
|
EP2007362B1
(de)
|
2006-04-04 |
2018-09-05 |
KG Acquisition LLC |
Orale darreichungsformen mit einem thrombozytenhemmer und säurehemmer
|
US8063050B2
(en)
|
2006-07-06 |
2011-11-22 |
Array Biopharma Inc. |
Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
|
UA99597C2
(ru)
*
|
2006-07-06 |
2012-09-10 |
Еррей Біофарма Інк. |
Пиримидилциклопентаны как ингибиторы акт протеинкиназ
|
DE602007011628D1
(de)
|
2006-07-06 |
2011-02-10 |
Array Biopharma Inc |
Dihydrofuropyrimidine als akt-proteinkinaseinhibitoren
|
WO2008006039A1
(en)
|
2006-07-06 |
2008-01-10 |
Array Biopharma Inc. |
Dihydrothieno pyrimidines as akt protein kinase inhibitors
|
RU2467747C2
(ru)
|
2006-07-25 |
2012-11-27 |
Векта Лтд. |
Композиции и способы для ингибирования секреции желудочной кислоты с использованием производных малых дикарбоновых кислот в сочетании с ppi
|
MX2009004475A
(es)
|
2006-10-27 |
2009-08-12 |
Univ Missouri |
Composiciones que comprenden agentes acido labiles que inhiben la bomba de protones, por lo menos otro agente farmaceuticamente activo y metodos de uso de las misma.
|
KR100954828B1
(ko)
*
|
2006-12-22 |
2010-04-27 |
주식회사유한양행 |
레바프라잔 함유 고체분산체 및 그의 제조방법
|
EP2173723B3
(de)
*
|
2007-07-05 |
2014-11-19 |
Array Biopharma Inc. |
Pyrimidylcyclopentane als inhibitoren der akt-proteinkinase
|
US9409886B2
(en)
|
2007-07-05 |
2016-08-09 |
Array Biopharma Inc. |
Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
|
US8846683B2
(en)
|
2007-07-05 |
2014-09-30 |
Array Biopharma, Inc. |
Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
|
CA2692502C
(en)
|
2007-07-05 |
2016-03-01 |
Array Biopharma Inc. |
Pyrimidyl cyclopentanes as akt protein kinase inhibitors
|
KR101624752B1
(ko)
*
|
2008-01-09 |
2016-05-26 |
어레이 바이오파마 인크. |
Akt 단백질 키나제 저해물질로써의 수산화된 피리미딜 시클로펜탄
|
WO2009089459A1
(en)
*
|
2008-01-09 |
2009-07-16 |
Array Biopharma Inc. |
Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
|
AU2009290712A1
(en)
*
|
2008-09-09 |
2010-03-18 |
Astrazeneca Ab |
Method for delivering a pharmaceutical composition to patient in need thereof
|
SG176724A1
(en)
|
2009-06-25 |
2012-01-30 |
Astrazeneca Ab |
Method for treating a patient at risk for developing an nsaid-associated ulcer
|
KR20120093140A
(ko)
*
|
2009-06-25 |
2012-08-22 |
포젠 인크. |
아스피린 치료를 필요로 하는 환자의 치료 방법
|
BRPI1013288A2
(pt)
*
|
2009-07-09 |
2016-03-29 |
Raqualia Pharma Inc |
uso de um composto, método de composição farmacêutica para o tratamento de doenças em que a motilidade gastrointestinal anormal está envolvida, kit e embalagem comercial que compreende uma composição farmacêutica contendo o composto
|
KR101739815B1
(ko)
|
2010-12-01 |
2017-05-26 |
주식회사유한양행 |
레바프라잔 또는 그의 염을 함유하는 주사용 액제 조성물
|
KR101730865B1
(ko)
*
|
2011-02-11 |
2017-04-27 |
주식회사유한양행 |
레바프라잔-함유 나노입자를 포함하는 경구투여용 약학 조성물 및 그의 제조방법
|
PL2678332T3
(pl)
*
|
2011-02-25 |
2016-12-30 |
|
Pochodne diaminopirymidyny i sposoby ich wytwarzania
|
CA2844699C
(en)
|
2011-04-01 |
2019-05-07 |
Genentech, Inc. |
Combinations of akt inhibitor compounds and abiraterone, and methods of use
|
TR201815685T4
(tr)
|
2011-04-01 |
2018-11-21 |
Genentech Inc |
Kanser tedavisi için akt ve mek inhibe edici bileşiklerin kombinasyonları.
|
CN102863423B
(zh)
*
|
2011-07-04 |
2014-09-17 |
天津药物研究院 |
一种制备异喹啉基取代的嘧啶衍生物的方法
|
EA028049B1
(ru)
|
2011-12-28 |
2017-10-31 |
Поузен Инк. |
Улучшенные композиции и способы доставки омепразола и ацетилсалициловой кислоты
|
WO2014060908A1
(en)
*
|
2012-10-17 |
2014-04-24 |
Lupin Limited |
Improved process for preparation of revaprazan hydrochloride
|
SG10201600149VA
(en)
|
2012-11-21 |
2016-02-26 |
Ptc Therapeutics Inc |
Substituted reverse pyrimidine bmi-1 inhibitors
|
CN102993173B
(zh)
*
|
2012-12-28 |
2014-09-03 |
山东大学 |
洛氟普啶的制备方法
|
KR101657616B1
(ko)
*
|
2013-05-24 |
2016-09-19 |
주식회사유한양행 |
피리미딘 고리를 포함하는 바이사이클릭 유도체 및 그의 제조방법
|
WO2015012210A1
(ja)
|
2013-07-23 |
2015-01-29 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
ヘテロ縮合環化合物
|
EP3039015B1
(de)
|
2013-08-30 |
2019-10-30 |
PTC Therapeutics, Inc. |
Substituierte pyrimidin-bmi-1 inhibitoren
|
EP3055301B1
(de)
|
2013-10-07 |
2019-11-20 |
Kadmon Corporation, LLC |
(2-(5-isoindolin-2-yl)pyrimidin-4-yl)-amin-derivate als rho kinase inhibitoren zur behandlung von autoimmun-erkrankungen
|
WO2015076800A1
(en)
|
2013-11-21 |
2015-05-28 |
Ptc Therapeutics, Inc. |
Substituted pyridine and pyrazine bmi-1 inhibitors
|
CN105601611A
(zh)
*
|
2014-11-19 |
2016-05-25 |
江苏天士力帝益药业有限公司 |
一种盐酸洛氟普啶多晶型物及其制备方法
|
CN105669642B
(zh)
|
2014-11-19 |
2020-06-09 |
江苏天士力帝益药业有限公司 |
一种盐酸洛氟普啶的制备方法
|
CN107405359B
(zh)
|
2015-11-25 |
2021-04-20 |
艾克萨姆治疗公司 |
包含美洛昔康的药物组合物
|
CN105399727A
(zh)
*
|
2015-12-02 |
2016-03-16 |
芷威(上海)化学科技有限公司 |
盐酸瑞伐拉赞新结晶形态
|
CN106995432A
(zh)
*
|
2016-01-25 |
2017-08-01 |
广东华南药业集团有限公司 |
一种瑞普拉生无水合物晶型及其制备方法和用途
|
CN106995431A
(zh)
*
|
2016-01-25 |
2017-08-01 |
广东华南药业集团有限公司 |
一种瑞普拉生水合物晶型及其制备方法和用途
|
HUE052749T2
(hu)
|
2017-01-04 |
2021-12-28 |
Axsome Therapeutics Inc |
Meloxicamot és rizatriptant tartalmazó gyógyászati készítmények
|
AU2018265411C1
(en)
|
2017-05-10 |
2021-01-28 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|